$7.67
3.23% yesterday
Nasdaq, Nov 26, 10:00 pm CET
ISIN
SG9999014716
Symbol
WVE

Wave Life Sciences Ltd. Stock price

$7.67
+0.05 0.66% 1M
+1.72 28.91% 6M
-4.70 38.00% YTD
-7.16 48.28% 1Y
+3.20 71.59% 3Y
-1.54 16.72% 5Y
-8.41 52.30% 10Y
-8.33 52.06% 20Y
Nasdaq, Closing price Wed, Nov 26 2025
+0.24 3.23%
ISIN
SG9999014716
Symbol
WVE
Industry

Key metrics

Basic
Market capitalization
$1.2b
Enterprise Value
$982.4m
Net debt
positive
Cash
$196.2m
Shares outstanding
160.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
10.8 | 24.9
EV/Sales
9.0 | 20.7
EV/FCF
negative
P/B
8.9
Financial Health
Equity Ratio
61.7%
Return on Equity
-44.6%
ROCE
-87.4%
ROIC
857.0%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$109.2m | $47.4m
EBITDA
$-132.4m | $-191.5m
EBIT
$-135.9m | $-198.9m
Net Income
$-122.2m | $-188.2m
Free Cash Flow
$-198.5m
Growth (TTM | estimate)
Revenue
103.8% | -56.2%
EBITDA
10.6% | -79.8%
EBIT
10.7% | -80.2%
Net Income
14.4% | -94.0%
Free Cash Flow
-40.4%
Margin (TTM | estimate)
Gross
-
EBITDA
-121.2% | -403.9%
EBIT
-124.4%
Net
-111.9% | -397.0%
Free Cash Flow
-181.8%
More
EPS
$-0.7
FCF per Share
$-1.2
Short interest
12.3%
Employees
288
Rev per Employee
$380.0k
Show more

Is Wave Life Sciences Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,049 stocks worldwide.

Wave Life Sciences Ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Wave Life Sciences Ltd. forecast:

18x Buy
90%
2x Hold
10%

Analyst Opinions

20 Analysts have issued a Wave Life Sciences Ltd. forecast:

Buy
90%
Hold
10%

Financial data from Wave Life Sciences Ltd.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
109 109
104% 104%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 70 70
25% 25%
64%
- Research and Development Expense 175 175
17% 17%
160%
-132 -132
11% 11%
-121%
- Depreciation and Amortization 3.51 3.51
14% 14%
3%
EBIT (Operating Income) EBIT -136 -136
11% 11%
-124%
Net Profit -122 -122
14% 14%
-112%

In millions USD.

Don't miss a Thing! We will send you all news about Wave Life Sciences Ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Wave Life Sciences Ltd. Stock News

Neutral
Seeking Alpha
16 days ago
Wave Life Sciences Ltd. ( WVE ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Kate Rausch - Head of Investor Relations Paul Bolno - President, CEO & Director Kyle Moran - CFO & Principal Accounting Officer Erik Ingelsson - Chief Scientific Officer Christopher Wright - Chief Medical Officer Chandra Vargeese - Chief Technology Officer Conference Call Participants Joon L...
Neutral
GlobeNewsWire
17 days ago
WVE-007, an INHBE GalNAc-siRNA for obesity designed to drive fat loss while preserving muscle mass, achieved dose-dependent, mean reductions of Activin E of up to 85% in INLIGHT clinical trial, exceeding levels that led to weight loss and prevention of rebound weight gain following cessation of GLP-1 in preclinical models  Activin E reduction in lowest single dose cohort of INLIGHT was sustaine...
Neutral
GlobeNewsWire
20 days ago
CAMBRIDGE, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that members of Wave's management team are scheduled to participate in two upcoming investor conferences in November.
More Wave Life Sciences Ltd. News

Company Profile

Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Head office Singapore
CEO Paul Bolno
Employees 288
Founded 2012
Website www.wavelifesciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today